Product Description
Better than typical antipsychotics
Allows more refractory time between episodes than typical antipsychotics We conclude that there is a very high rate of discontinuation of the initial antipsychotic medications for various reasons with risperidone having an overall longer time to discontinuation compared with firstgeneration antipsychotic medications
Liew A et al J Psychopharmacol 2010 Mar
Approved by US FDA in adolescent schizophrenia
Risperidone has been approved by the Food and Drug Administration for the treatment of schizophrenia in the adolescent population
Madaan VDrugs Today Barc 2009 Jan4515562
Indicated in
Acute and chronic schizophrenia
Bipolar disorders
Tourettes disorder
Behaviour disorder in dementia
Disruptive behaviour disorders in children